HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

LANCASTER GROUP USA's BECKER BECOMING CEO AND PRESIDENT

This article was originally published in The Rose Sheet

Executive Summary

LANCASTER GROUP USA's BECKER BECOMING CEO AND PRESIDENT while retaining his duties as chief operating officer for the Benckiser Group division, the company announced Dec. 7. The appointment is effective immediately. Norbert Becker, 46, is succeeding Richard Hartigan, who is leaving at the end of the year, the firm said, because of a shift in the "scope of responsibilities" held by Lancaster Group USA after the relocation of the Lancaster Group Worldwide marketing offices to New York in 1993 ("The Rose Sheet" May 3, In Brief). Hartigan served as president and CEO of the New York-based company since January 1991. Prior to that, he was with Estee Lauder, most recently as exec VP.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001120

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel